Samjo Capital’s Exagen XGN Stock Holding History

Samjo Capital’s Portfolio XGN Stock Details XGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-295,000	Closed	-$4.01M	–	20
2021 Q3	$4.01M	Buy	295,000 +90,000	+44%	+$1.2M	2.95%	12
2021 Q2	$3.07M	Buy	205,000 +55,000	+37%	+$843K	2.08%	15
2021 Q1	$2.63M	Buy	+150,000	New	+$2.67M	1.95%	14

Other funds holding XGN

CAC

Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

PIM

Platinum Investment Management Sydney Australia 2000, Australia $397M AUM 63.96% 1-Year Est. Return

PCM

Perkins Capital Management Wayzata, Minnesota $107M AUM 82.62% 1-Year Est. Return

Samjo Capital's XGN Position: Q4 2021 in Review

Samjo Capital sold out of Exagen (XGN) in Q4 2021, closing a stake of 295,000 shares — an estimated $4.01M sold.

Samjo Capital first reported a position in XGN in Q1 2021 and held it in 3 quarters. The position peaked at $4.01M in Q3 2021. 53 funds tracked by Wall St. Rank hold XGN as of Q4 2021.

Samjo Capital reported no remaining Exagen position as of Q4 2021 after selling out during the quarter.
Samjo Capital sold 295,000 Exagen shares in Q4 2021, an estimated $4.01M.
Samjo Capital first reported a position in Exagen in Q1 2021 and held it in 3 quarters.
Samjo Capital's Exagen position peaked at $4.01M in Q3 2021.
53 funds tracked by Wall St. Rank held Exagen as of Q4 2021.

Based on Samjo Capital's 13F filing for Q4 2021, filed 8 Feb 2022.